NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer
NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who...
Scan predicts whether therapy or meds will best lift depression
Scan predicts whether therapy or meds will best lift depression Pre-treatment scans of brain activity predicted whether depressed patients would best achieve remission with an antidepressant...
Verastem Receives Orphan Drug Designation in the EU for VS-6063 in Mesothelioma
Cambridge, MA - June 13, 2013 - Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that VS-6063 has...
Biomarker could help scientists choose the right cell line when conducting stem cell experiments
WNT3 helps pinpoint stem cell lines primed to turn into liver, pancreas and similar tissues; other genes may help select other lineages Boston, Mass.— According to researchers at Boston...
Two Biomarkers Predict Increased Risk For "Silent" Strokes
Two Biomarkers Predict Increased Risk For "Silent" Strokes Released: 6/4/2013 10:00 AM EDT Source Newsroom: Methodist Hospital, Houston Newswise — HOUSTON -- ( June 4, 2013 ) --...
Pronota Is to Receive Patent on Biomarker for Diagnosing Renal Failure in the US Despite Prometheus
Pronota Is to Receive Patent on Biomarker for Diagnosing Renal Failure in the US Despite Prometheus GHENT, Belgium, June 6, 2013 /PRNewswire/ -- The United States Patent and Trade Office (USPTO) has...
CANCER RESEARCH UK AND CRT COLLABORATE WITH ABCODIA TO DISCOVER AND DEVELOP TESTS FOR EARLY DIAGNOSIS OF CANCER
CANCER RESEARCH UK AND CRT COLLABORATE WITH ABCODIA TO DISCOVER AND DEVELOP TESTS FOR EARLY DIAGNOSIS OF CANCER CANCER RESEARCH UK and its commercial arm, Cancer Research Technology (CRT), have...
Biomarker identification may lead to new noninvasive test for colorectal cancer detection
Biomarker identification may lead to new noninvasive test for colorectal cancer detection Serum DNA analysis allows detection of early disease, say researchers in The Journal of Molecular Diagnostics...
New test assesses gestational diabetes risk early in pregnancy
New test assesses gestational diabetes risk early in pregnancy Gestation diabetes risk can be identified through biomarker levels during first trimester Chevy Chase, MD—Levels of a biomarker in...
U of A medical researchers ID genetic marker for sporadic breast cancer
U of A medical researchers ID genetic marker for sporadic breast cancer Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer – one of a...
BCC Research's Report Projects the Global Market for Central Nervous System Biomarkers to Reach Nearly $5.1 Billion in 2017
Wellesley, MA (PRWEB) May 28, 2013 The global central nervous system (CNS) biomarker market was valued at nearly $2 billion in 2012. The market is projected to reach nearly $5.1 billion in 2017 after...
Cenix BioScience and Debiopharm Group™ collaborate to identify predictive biomarkers
Cenix BioScience and Debiopharm Group™ collaborate to identify predictive biomarkers Lausanne, Switzerland and Dresden, Germany – May 23, 2013 - Cenix BioScience, a leading preclinical...
New diagnostic technology may lead to individualized treatments for prostate cancer
New diagnostic technology may lead to individualized treatments for prostate cancer NanoVelcro chip device captures and isolates potentially high-risk cancer cells LOS ANGELES – A research...
Key find for early bladder cancer treatment
Key find for early bladder cancer treatment 23 May 2013 Lund University Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment,...
Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer Exciting new precision medicine tool for diagnosing and...
Mayo Clinic: Molecular Marker from Pancreatic 'Juices' Helps Identify Pancreatic Cancer
Mayo Clinic: Molecular Marker from Pancreatic 'Juices' Helps Identify Pancreatic Cancer Sunday, May 19, 2013 JACKSONVILLE, Fla. — Researchers at Mayo Clinic have developed a promising...
VEGF may not be relevant biomarker for advanced prostate cancer
'This study confirms that VEGF is not a path forward to tackling this disease' PHILADELPHIA—The well-studied protein VEGF does not appear to have any prognostic or predictive value for...
TCGA Researchers Identify Potential Drug Targets, Markers for Leukemia Risk
Investigators for The Cancer Genome Atlas (TCGA) Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia...
OGT Marks World Lupus Day with Novel Biomarker Panel to Support Earlier SLE Diagnosis
OGT Marks World Lupus Day with Novel Biomarker Panel to Support Earlier SLE Diagnosis 10 May 2013 Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to...
Tumor-Activated Protein Promotes Cancer Spread
Tumor-Activated Protein Promotes Cancer Spread Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter...
